
Ophthalmology Devices Market by Devices (Diagnostic & Monitoring Devices, Surgical Devices, Vision Care), Application (Academy & Research Laboratory, Ambulatory Surgical Centers, Hospitals & Ophthalmology Clinics) - Global Forecast 2024-2030
Description
Ophthalmology Devices Market by Devices (Diagnostic & Monitoring Devices, Surgical Devices, Vision Care), Application (Academy & Research Laboratory, Ambulatory Surgical Centers, Hospitals & Ophthalmology Clinics) - Global Forecast 2024-2030
The Ophthalmology Devices Market size was estimated at USD 67.94 billion in 2023 and expected to reach USD 70.93 billion in 2024, at a CAGR 4.52% to reach USD 92.61 billion by 2030.
Ophthalmology devices encompass various instruments, equipment, and technology designed to diagnose, treat, and manage eye conditions and diseases. These devices are integral to the field of ophthalmology, a medical specialty concentrated on eye care, enabling healthcare professionals to enhance the quality of life for patients through enhanced vision care. The category of ophthalmology devices includes diagnostic and surgical instruments, corrective and therapeutic devices, and vision care products. Examples range from sophisticated imaging systems used to visualize and analyze eye structures, surgical instruments for procedures including cataract removal and LASIK, to corrective lenses and contact lenses designed to improve vision. The growing number of elderly individuals, more prone to eye diseases and rising instances of eye-related diseases globally fuel the demand for ophthalmology devices. However, adverse recalls of ophthalmology devices hinder market growth. Nevertheless, diagnostics and surgical equipment innovations with the establishment of high-standard and certified eye clinics are expected to create opportunities for market growth.
Regional Insights
The Americas has evolved in the ophthalmology devices market, attributed to strong research and development capabilities and a high prevalence of eye-related disorders. There is a marked shift towards minimally invasive surgeries, and the adoption of advanced imaging technologies is rising. The latest patents in the region emphasize smart contact lenses and AI-driven diagnostic tools. The government and private sector's investment in healthcare infrastructure and ophthalmic research fosters the growth of this market in the Americas. In the Asia-Pacific, the ophthalmology devices market is expanding rapidly due to its large population base, growing elderly population, and rising awareness of eye health. The country is witnessing a surge in domestic manufacturers entering the market, backed by government support for the biotechnology and medical device sectors. Furthermore, countries in this region focus on innovative products with precision and quality, with significant investments in R&D revealing a trend towards robotic surgery and advanced imaging techniques. In addition, the market is price-sensitive, with a high demand for cost-effective solutions alongside a growing acceptance of advanced technologies. Stringent regulatory standards and high-quality healthcare services characterize the EU's market. Innovative device approvals and a focus on patient safety underpin the market. The adoption of digital eye care and teleophthalmology highlights the shift towards remote and minimally invasive patient care. On the other hand, the Middle East and Africa region presents a diverse market with varying levels of healthcare infrastructure. The gulf cooperation council (GCC) countries are investing in healthcare and the adoption of advanced ophthalmology devices, driven by government initiatives to improve healthcare services. In contrast, African countries are witnessing gradual growth with an increasing focus on treating preventable blindness and eye diseases.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Ophthalmology Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Increasing prevalence of eye diseases worldwide
Rising awareness of eye health and improved access to eye care
Expanding preference for minimally invasive surgeries
Market Restraints
Adverse recalls of ophthalmology devices
Market Opportunities
Technological advancements in ophthalmological devices
Establishment of high-standard and certified eye clinics
Market Challenges
Technical limitations and operational issues of the devices
Market Segmentation Analysis
Devices: Burgeoning adoption of diagnostic and monitoring devices in ophthalmology crucial for the management of eye diseases
Application: Evolving usage of ophthalmology devices in hospitals and ophthalmology clinics
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Ophthalmology Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Ophthalmology Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Zeiss Acquires Dutch Ophthalmic Research Center in USD 1 Billion Deal
Carl Zeiss Meditec announced its strategic acquisition of the Dutch Ophthalmic Research Center (DORC), a move to bolster its ophthalmic device offerings. This acquisition, valued at approximately EUR 985 million (USD 1.07 billion), aims to enhance Zeiss's portfolio in vitreoretinal surgical devices significantly.
Kubota Vision Announces Agreement with AUROLAB for Development, Manufacturing, Supply, and Distribution License of eyeMO
Kubota Vision Inc., an ophthalmology company under Kubota Pharmaceutical Holdings Co., Ltd., announced a strategic partnership with AUROLAB, the manufacturing arm of the globally recognized Aravind Eye Care Hospital System. Through this collaboration, Kubota Vision aims to grant AUROLAB an exclusive license to develop, manufacture, and distribute eyeMO, an innovative, cost-effective, portable ophthalmic OCT device designed for home and office use, remotely monitoring retinal diseases.
Bausch + Lomb Announces U.S. Launch of StableVisc Cohesive Ophthalmic Viscosurgical Device and TotalVisc Viscoelastic System
Bausch + Lomb, a global eye health corporation, announced the launch of two innovative ophthalmic viscosurgical devices (OVDs) in the U.S.: StableVisc and TotalVisc Viscoelastic System. These products are engineered to offer unparalleled dual-action protection during cataract surgery, a crucial intervention for preserving vision. The distinctive combination of these viscosurgical solutions, particularly with TotalVisc being the sole U.S. dual pack offering both a cohesive and dispersive OVD enhanced with sorbitol, represents a significant advancement in surgical safety and efficacy, promising optimal outcomes for patients undergoing cataract surgery.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Ophthalmology Devices Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Ophthalmology Devices Market, highlighting leading vendors and their innovative profiles. These include Alcon Inc., Bausch & Lomb Incorporated by Valeant Pharmaceuticals International, Canon Medical Systems Corporation, Carl Zeiss AG, ClearSight, Diamatrix Ltd., EssilorLuxottica, Eyenovia, Inc., F. Hoffmann-La Roche AG, GWS Surgicals LLP, Haag-Streit Group by Metall Zug, Halma PLC, HEINE Optotechnik, Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services, Inc., Luneau Technology Operations SAS, Nidek Co. Ltd., Ophtec B.V., Ophtechnics Unlimited, Paramount Surgimed Ltd., STAAR Surgical Company, Stryker Corporation, Topcon Corporation, Unique Technologies, Inc., and Ziemer Ophthalmic Systems AG.
Market Segmentation & Coverage
This research report categorizes the Ophthalmology Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
Devices
Diagnostic & Monitoring Devices
Autorefractors & Keratometers
Corneal Topography Systems
Ophthalmic Ultrasound Imaging Systems
Optical Coherence Tomography Scanners
Perimeters/Visual Field Analysers
Phoropters
Retinoscope
Specular Microscope
Wavefront Aberrometer
Surgical Devices
Cataract Surgery Devices
Glaucoma Surgery Devices
Ophthalmic Microscopes
Refractive Surgery Devices
Vitreoretinal Surgery Devices
Vision Care
Application
Academy & Research Laboratory
Ambulatory Surgical Centers
Hospitals & Ophthalmology Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
191 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of eye diseases worldwide
- 5.1.1.2. Rising awareness of eye health and improved access to eye care
- 5.1.1.3. Expanding preference for minimally invasive surgeries
- 5.1.2. Restraints
- 5.1.2.1. Adverse recalls of ophthalmology devices
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in ophthalmological devices
- 5.1.3.2. Establishment of high-standard and certified eye clinics
- 5.1.4. Challenges
- 5.1.4.1. Technical limitations and operational issues of the devices
- 5.2. Market Segmentation Analysis
- 5.2.1. Devices: Burgeoning adoption of diagnostic and monitoring devices in ophthalmology crucial for the management of eye diseases
- 5.2.2. Application: Evolving usage of ophthalmology devices in hospitals and ophthalmology clinics
- 5.3. Market Disruption Analysis
- 5.4. Porter’s Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
- 5.5. Value Chain & Critical Path Analysis
- 5.6. Pricing Analysis
- 5.7. Technology Analysis
- 5.8. Patent Analysis
- 5.9. Trade Analysis
- 5.10. Regulatory Framework Analysis
- 6. Ophthalmology Devices Market, by Devices
- 6.1. Introduction
- 6.2. Diagnostic & Monitoring Devices
- 6.3. Surgical Devices
- 6.4. Vision Care
- 7. Ophthalmology Devices Market, by Application
- 7.1. Introduction
- 7.2. Academy & Research Laboratory
- 7.3. Ambulatory Surgical Centers
- 7.4. Hospitals & Ophthalmology Clinics
- 8. Americas Ophthalmology Devices Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Ophthalmology Devices Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Ophthalmology Devices Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. Market Share Analysis, 2023
- 11.2. FPNV Positioning Matrix, 2023
- 11.3. Competitive Scenario Analysis
- 11.3.1. Zeiss Acquires Dutch Ophthalmic Research Center in USD 1 Billion Deal
- 11.3.2. Kubota Vision Announces Agreement with AUROLAB for Development, Manufacturing, Supply, and Distribution License of eyeMO
- 11.3.3. Bausch + Lomb Announces U.S. Launch of StableVisc Cohesive Ophthalmic Viscosurgical Device and TotalVisc Viscoelastic System
- 11.4. Strategy Analysis & Recommendation
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.2. Key Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.